Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.14
-0.16 (-2.54%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $636.75 million as of October 30, 2026. It is the 12,674th most valuable company in the world and the 2,558th biggest in the United States. Its market cap has increased by 66.94% in one year.
Market Cap
636.75M
Enterprise Value
329.50M
1-Year Change
66.94%
Global Rank
Country Rank
#2,558 United States
Category
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $636.75M, an increase of 60.09%. That is a compound annual growth rate of 9.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 636.75M | 83.98% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 685.17M |
| Gyre Therapeutics | 679.68M |
| Iambic Therapeutics | 676.88M |
| SL Science Holding | 667.21M |
| Adlai Nortye Group | 662.01M |
| Candel Therapeutics | 661.89M |
| Immix Biopharma | 661.57M |
| Lexicon Pharmaceuticals | 658.53M |